Teva to divest active pharmaceutical ingredient business
Source: Reuters Teva Pharmaceutical Industries (TEVA.TA), opens new tab will divest its active pharmaceutical ingredient (API) unit to focus on its core business, the world’s largest generic drugs maker said on Wednesday. The API unit, which brought in revenue of $1.05 billion in 2022, makes pharmaceutical ingredients that are used in both generic and branded medicines, and […]
API Market to reach a USD 839.1 Billion by 2033
Source: Yahoo Finance The global demand for pharmaceutical products, including both branded and generic drugs, has been steadily rising. As a result, the need for active pharmaceutical ingredients, which are the essential components of these medications, has grown substantially. New York, Jan. 23, 2024 (GLOBE NEWSWIRE) — According to Market.us, the global Active Pharmaceutical Ingredient market size […]